Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cell

• Publication date

  2013-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cell.2013.06.005PMID 23827675PMCID PMC4015106
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comprehensive molecular portraits of human breast tumours

  2013cited by this paper
• Comprehensive molecular portraits of human breast tumors

  2012cited by this paper
• Cancer stem cells: current status and evolving complexities.

  2012influential reference
• Slug and Sox9 cooperatively determine the mammary stem cell state.

  2012cited by this paper
• Interactions between cancer stem cells and their niche govern metastatic colonization

  2011cited by this paper
• An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition

  2011cited by this paper
• Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state

  2011influential reference
• Epigenetic Regulation of Cell Type–Specific Expression Patterns in the Human Mammary Epithelium

  2011cited by this paper
• Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells.

  2011cited by this paper
• A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

  2010cited by this paper
• ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays.

  2009cited by this paper
• The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

  2009cited by this paper
• Epithelial-mesenchymal transitions in development and disease.

  2009cited by this paper
• Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition

  2008cited by this paper
• Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy

  2008cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008influential reference
• The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

  2008cited by this paper
• A chromatin landmark and transcription initiation at most promoters in human cells.

  2007cited by this paper
• A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification.

  2007cited by this paper
• Chromatin immunoprecipitation and microarray-based analysis of protein location

  2006cited by this paper
• A bivalent chromatin structure marks key developmental genes in embryonic stem cells.

  2006cited by this paper
• Tumour stem cells and drug resistance

  2005cited by this paper
• Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein

  2004cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells.

  2003influential reference
• EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

  2003cited by this paper
• Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites.

  2002cited by this paper
• Histone methyltransferase activity of a Drosophila Polycomb group repressor complex.

  2002cited by this paper
• Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein.

  2002cited by this paper
• Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing

  2002cited by this paper
• Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

  2001cited by this paper
• Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

  1997cited by this paper

• Mechanobiological Ultrasound Simulation Reveals Suppression of Epithelial-to-Mesenchymal Transition and Stemness Programs in Colorectal Cancer.

  2026cites this paper
• ZEB1 Promotes Alternate Lengthening of Telomeres at Multiple Levels

  2026cites this paper
• Intrinsic cellular heterogeneity directs divergent epithelial-to-mesenchymal transition outcomes.

  2026cites this paper
• Integrated multicenter single-cell atlas of bladder cancer reveals tumor heterogeneity associated with immunotherapy.

  2026cites this paper
• Breast Cancer Multicellular Spheroid Models—A Tool for Studying Cancer Biology; a Possible Platform for Drug Screening and Personalized Medicine

  2026cites this paper
• Polycomb repressive complex 2 (PRC2) pathway’s role in cancer cell plasticity and drug resistance

  2025cites this paper
• Cancer-specific bivalent promoters featuring low-level H3K27me3 signals favor active transcription and govern the cancer cell state transition.

  2025cites this paper
• Revealing dynamic temporal trajectories and underlying regulatory networks with Cflows

  2025cites this paper
• Research progress on cancer-related epigenetic switches

  2025cites this paper
• Chromatin looping-based CRISPR screen identifies TLK2 as chromatin loop formation regulator in cancer stemness plasticity

  2025cites this paper
• Epithelial-mesenchymal transition.

  2025cites this paper
• The FUS/COL11A1/ZEB1 Axis Contributes to the Development of Oral Squamous Cell Carcinoma.

  2025cites this paper
• Tumour Cell Size Control and Its Impact on Tumour Cell Function

  2025cites this paper
• Reciprocal Modulation of Tumour and Immune Cell Motility: Uncovering Dynamic Interplays and Therapeutic Approaches

  2025cites this paper
• Nicotine‐driven enhancement of tumor malignancy in triple‐negative breast cancer via additive regulation of CHRNA9 and IGF1R

  2025cites this paper
• Inhibition of mitochondrial genome-encoded mitomiR-3 contributes to ZEB1 mediated GPX4 downregulation and pro-ferroptotic lipid metabolism to induce ferroptosis in breast cancer cells.

  2025cites this paper
• Widespread activation and critical role of EMT and stemness in the neuroendocrine differentiation of prostate cancer (Review)

  2025cites this paper
• The epipliancy journey: Tumor initiation at the mercy of identity crisis and epigenetic drift.

  2025cites this paper
• The interplay of DNA damage, epigenetics and tumour heterogeneity in driving cancer cell fitness

  2025cites this paper
• Oxidative stress-induced ZEB1 acetylation drives a hybrid epithelial-mesenchymal phenotype and promotes lung metastasis in triple-negative breast cancer

  2025cites this paper
• Luminal and Basal Subtypes Across Carcinomas: Molecular Programs Beyond Tissue of Origin

  2025cites this paper
• Inflammation awakens dormant cancer cells by modulating the epithelial-mesenchymal phenotypic state.

  2025cites this paper
• Macrophages foster anti-tumor immunity by ZEB1-dependent cytotoxic T cell chemoattraction

  2025influential citation
• Metastasis and chemoresistance in breast cancer: Crucial function of ZEB1/2 proteins.

  2025cites this paper
• Unraveling the underlying mechanisms of cancer stem cells in therapeutic resistance for optimizing treatment strategies

  2025cites this paper
• Chromatin Organization Governs Transcriptional Response and Plasticity of Cancer Stem Cells

  2025cites this paper
• Epithelial–mesenchymal cell state heterogeneity predetermines differential phospho-signaling responses to EGF stimulation

  2025cites this paper
• Co-targeting BMI1 and MYC to eliminate cancer stem cells in squamous cell carcinoma.

  2025cites this paper
• Epigenetic regulation of cancer stemness

  2025cites this paper
• Safely Targeting Cancer, the Wound That Never Heals, Utilizing CBP/Beta-Catenin Antagonists

  2025cites this paper
• MACC1 ablation suppresses the dedifferentiation process of non-CSCs in lung cancer through stabilizing KLF4

  2024cites this paper
• PTEN depletion reduces H3K27me3 levels to promote epithelial-to-mesenchymal transition in epithelial colorectal cancer cells

  2024cites this paper
• Orchestrated desaturation reprogramming from stearoyl‐CoA desaturase to fatty acid desaturase 2 in cancer epithelial‐mesenchymal transition and metastasis

  2024cites this paper
• Epigenomic heterogeneity as a source of tumour evolution

  2024cites this paper
• Cancer stem cells in meningiomas: novel insights and therapeutic implications

  2024cites this paper
• RNA binding protein ZCCHC24 promotes tumorigenicity in triple-negative breast cancer

  2024cites this paper
• Integrative RNA-Sequencing Analysis Reveals T-Cell Exhaustion Signatures and Immune Cell Infiltration in Hepatocellular Carcinoma

  2024cites this paper
• Phosphocreatine promotes epigenetic reprogramming to facilitate glioblastoma growth through stabilizing BRD2.

  2024cites this paper
• DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma

  2024cites this paper
• Exploiting Transcription Factors to Target EMT and Cancer Stem Cells for Tumor Modulation and Therapy.

  2024cites this paper
• Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets

  2024cites this paper
• Targeting initial tumour–osteoclast spatiotemporal interaction to prevent bone metastasis

  2024cites this paper
• RNA regulatory mechanisms controlling TGF-β signaling and EMT in cancer.

  2024cites this paper
• Research Progress of Breast Cancer Stem Cell Stemness and Breast Cancer Recurrence

  2024cites this paper
• Cell-state transitions and density-dependent interactions together explain the dynamics of spontaneous epithelial-mesenchymal heterogeneity

  2024cites this paper
• Regulating epithelial-mesenchymal plasticity from 3D genome organization

  2024cites this paper
• Hallmarks of cancer stemness.

  2024cites this paper
• Pharmacological targeting of the cancer epigenome

  2024cites this paper
• An exosomal strategy for targeting cancer-associated fibroblasts mediated tumors desmoplastic microenvironments

  2024cites this paper
• Combinatorial Cooperativity in miR200-Zeb Feedback Network can Control Epithelial–Mesenchymal Transition

  2024cites this paper
• Differentiation stage-specific expression of transcriptional regulators for epithelial mesenchymal transition in dentate granule progenitors

  2024cites this paper
• Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer

  2024cites this paper
• Metformin overcomes chemoresistance by regulating stemness via KLF4 in oral squamous cell carcinoma.

  2024cites this paper
• Updates on altered signaling pathways in tumor drug resistance

  2024cites this paper
• Lipid metabolism dynamics in cancer stem cells: potential targets for cancers

  2024cites this paper
• Relationship of Signaling Pathways between RKIP Expression and the Inhibition of EMT-Inducing Transcription Factors SNAIL1/2, TWIST1/2 and ZEB1/2

  2024cites this paper
• A Multi-Omics Prognostic Model Capturing Tumor Stemness and the Immune Microenvironment in Clear Cell Renal Cell Carcinoma

  2024cites this paper
• The Zeb1-Cxcl1 axis impairs the antitumor immune response by inducing M2 macrophage polarization in breast cancer.

  2024cites this paper
• A dynamic model of inorganic arsenic-induced carcinogenesis reveals an epigenetic mechanism for epithelial-mesenchymal plasticity.

  2024cites this paper
• The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations

  2024cites this paper
• Association of epigenetic landscapes with heterogeneity and plasticity in pancreatic cancer.

  2024cites this paper
• The molecular determinants of phenotypic plasticity in homeostasis and neoplasia

  2024cites this paper
• Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal‐like Breast Cancer

  2024cites this paper
• The Impact of Inadequate Exposure to Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors on the Development of Resistance in Non-Small-Cell Lung Cancer Cells

  2024cites this paper
• Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors

  2024cites this paper
• Plasticity and resistance of cancer stem cells as a challenge for innovative anticancer therapies – do we know enough to overcome this?

  2024cites this paper
• Integrative analysis of chromatin accessibility and transcriptome landscapes in the induction of peritoneal fibrosis by high glucose

  2024cites this paper
• The importance of cancer-associated fibroblasts in targeted therapies and drug resistance in breast cancer

  2024influential citation
• Temporally-coordinated bivalent histone modifications of BCG1 enable fungal invasion and immune evasion

  2024cites this paper
• Colibactin-producing Escherichia coli enhance resistance to chemotherapeutic drugs by promoting epithelial to mesenchymal transition and cancer stem cell emergence

  2024cites this paper
• The Significance of Epithelial Mesenchymal Transition (EMT) in Cancer Metastasis

  2024cites this paper
• Glucocorticoid receptor: a harmonizer of cellular plasticity in breast cancer—directs the road towards therapy resistance, metastatic progression and recurrence

  2024cites this paper
• Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance

  2024cites this paper
• Comprehensive Review on the Effect of Stem Cells in Cancer Progression

  2024cites this paper
• MicroRNA-561-3p indirectly regulates the PD-L1 expression by targeting ZEB1, HIF1A, and MYC genes in breast cancer

  2024cites this paper
• Bivalent chromatin: a developmental balancing act tipped in cancer

  2024cites this paper
• Spatial and Temporal Relationship between Epithelial–Mesenchymal Transition (EMT) and Stem Cells in Cancer

  2024influential citation
• Tumor suppressor FRMD3 controls mammary epithelial cell fate determination via notch signaling pathway

  2024cites this paper
• The evolutionary theory of cancer: challenges and potential solutions

  2024cites this paper
• The mesodermal and myogenic specification of hESCs depend on ZEB1 and are inhibited by ZEB2.

  2023cites this paper
• Targeting Breast Cancer Stem Cells through Retinoids: A New Hope for Treatment.

  2023cites this paper
• PSmad3+/Olig2− expression defines a subpopulation of gfap-GFP+/Sox9+ neural progenitors and radial glia-like cells in mouse dentate gyrus through embryonic and postnatal development

  2023cites this paper
• Dynamical transition of phenotypic states in breast cancer system with Lévy noise

  2023cites this paper
• ZEB1 promotes non-homologous end joining double-strand break repair

  2023cites this paper
• Dynamical hallmarks of cancer: phenotypic switching in melanoma and epithelial-mesenchymal plasticity.

  2023cites this paper
• The Transcriptional and Epigenetic Landscape of Cancer Cell Lineage Plasticity.

  2023cites this paper
• Tumor matrix stiffness provides fertile soil for cancer stem cells

  2023cites this paper
• Multi-omics analysis of human mesenchymal stem cells shows cell aging that alters immunomodulatory activity through the downregulation of PD-L1

  2023cites this paper
• Hypoxia induced responses are reflected in the stromal proteome of breast cancer

  2023cites this paper
• Unpacking the Complexity of Epithelial Plasticity: From Master Regulator Transcription Factors to Non-Coding RNAs

  2023cites this paper
• IFNγ-induced stem-like state of cancer cells as a driver of metastatic progression following immunotherapy.

  2023cites this paper
• IGJ suppresses breast cancer growth and metastasis by inhibiting EMT via the NF-κB signaling pathway

  2023cites this paper
• Single nuclei chromatin accessibility and transcriptomic map of breast tissues of women of diverse genetic ancestry

  2023cites this paper
• Combinatorial cooperativity can facilitate epithelial-mesenchymal transition in a miR200-Zeb feedback network

  2023cites this paper
• WNT-Conditioned Mechanism of Exit from Postchemotherapy Shock of Differentiated Tumour Cells

  2023cites this paper
• Next generation organoid engineering to replace animals in cancer drug testing.

  2023cites this paper
• Rab1A-Mediated Exosomal Sorting of miR-200c Enhances Breast Cancer Lung Metastasis

  2023cites this paper
• The Intricate Interplay between Cancer Stem Cells and Oncogenic miRNAs in Breast Cancer Progression and Metastasis

  2023cites this paper
• PKM2 dictates the poised chromatin state of PFKFB3 promoter to enhance breast cancer progression

  2023cites this paper
• Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer

  2023cites this paper